| Gene | GDB AccessionID | Location | OMIM Link |
| ACAA1 |
GDB:119643 | 3p23-3p22 |
PEROXISOMAL 3-OXOACYL-COENZYME A THIOLASE DEFICIENCY
|
| AGTR1 |
GDB:132359 | 3q21-3q25 |
ANGIOTENSIN II RECEPTOR, VASCULAR TYPE 1; AT2R1
|
| AHSG |
GDB:118985 | 3q27-3q27 |
ALPHA-2-HS-GLYCOPROTEIN; AHSG
|
| AMT |
GDB:132138 | 3p21.3-3p21.2 3p21.2-3p21.1 |
HYPERGLYCINEMIA, ISOLATED NONKETOTIC, TYPE II; NKH2
|
| ARP |
GDB:9959049 | 3p21.1-3p21.1 |
ARGININE-RICH PROTEIN
|
| BBS3 |
GDB:376501 | 3p-3p 3p12.3-3q11.1 |
BARDET-BIEDL SYNDROME, TYPE 3; BBS3
|
| BCHE |
GDB:120558 | 3q26.1-3q26.2 |
BUTYRYLCHOLINESTERASE; BCHE
|
| BCPM |
GDB:433809 | 3q21-3q21 |
BENIGN CHRONIC PEMPHIGUS; BCPM
|
| BPES |
GDB:129025 | 3q22-3q23 |
BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS; BPES
|
| BTD |
GDB:309078 | 3p25-3p25 |
BIOTINIDASE; BTD
|
| CACT |
GDB:6503297 | 3p21.31-3p21.31 |
CARNITINE-ACYLCARNITINE TRANSLOCASE; CACT
|
| CASR |
GDB:134196 | 3q21-3q24 |
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL; HHC1
|
| CCR2 |
GDB:337364 | 3p21-3p21 |
CHEMOKINE (C-C) RECEPTOR 2; CMKBR2
|
| CCR5 |
GDB:1230510 | 3p21-3p21 |
CHEMOKINE (C-C) RECEPTOR 5; CMKBR5
|
| CDL1 |
GDB:136344 | 3q26.3-3q26.3 |
DE LANGE SYNDROME; CDL
|
| CMT2B |
GDB:604021 | 3q13-3q22 |
CHARCOT-MARIE-TOOTH DISEASE, NEURONAL TYPE, B; CMT2B
|
| COL7A1 |
GDB:128750 | 3p21-3p21 3p21.3-3p21.3 |
COLLAGEN, TYPE VII, ALPHA-1; COL7A1
|
| CP |
GDB:119069 | 3q23-3q25 3q21-3q24 |
CERULOPLASMIN; CP
|
| CTNNB1 |
GDB:141922 | 3p22-3p22 3p21.3-3p21.3 |
CATENIN, BETA 1; CTNNB1
|
| DEM |
GDB:681157 | 3p12-3q11 |
DEMENTIA, FAMILIAL NONSPECIFIC; DEM
|
| ETM1 |
GDB:9732523 | 3q13-3q13 |
TREMOR, HEREDITARY ESSENTIAL 1; ETM1
|
| FANCD |
GDB:698345 | 3pter-3p24.2 |
FANCONI PANCYTOPENIA, COMPLEMENTATION GROUP D
|
| FIH |
GDB:9955790 | 3q13-3q13 |
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH
|
| GBE1 |
GDB:138442 | 3p12-3p12 |
GLYCOGEN STORAGE DISEASE IV
|
| GLB1 |
GDB:119987 | 3p22-3p21.33 3p21.33-3p21.33 |
GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I
|
| GLC1C |
GDB:3801941 | 3q21-3q24 |
GLAUCOMA 1, OPEN ANGLE, C; GLC1C
|
| GNAI2 |
GDB:120516 | 3p21.3-3p21.2 |
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-INHIBITING, POLYPEPTIDE-2;
|
| GNAT1 |
GDB:119277 | 3p21.3-3p21.2 |
GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-TRANSDUCING, POLYPEPTIDE
|
| GP9 |
GDB:126370 | 3pter-3qter |
PLATELET GLYCOPROTEIN IX; GP9
|
| GPX1 |
GDB:119282 | 3q11-3q12 3p21.3-3p21.3 |
GLUTATHIONE PEROXIDASE; GPX1
|
| HGD |
GDB:203935 | 3q21-3q23 |
ALKAPTONURIA; AKU
|
| HRG |
GDB:120055 | 3q27-3q27 |
HISTIDINE-RICH GLYCOPROTEIN; HRG; HRGP
|
| ITIH1 |
GDB:120107 | 3p21.2-3p21.1 |
INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN-1; ITIH1; IATIH; ITIH
|
| KNG |
GDB:125256 | 3q27-3q27 |
FLAUJEAC FACTOR DEFICIENCY
|
| LPP |
GDB:1391795 | 3q27-3q28 |
LIM DOMAIN-CONTAINING PREFERRED TRANSLOCATION PARTNER IN LIPOMA; LPP
|
| LRS1 |
GDB:682448 | 3p21.1-3p14.1 |
LARSEN SYNDROME, AUTOSOMAL DOMINANT; LRS1
|
| MDS1 |
GDB:250411 | 3q26-3q26 |
MYELODYSPLASIA SYNDROME 1; MDS1
|
| MITF |
GDB:214776 | 3p14.1-3p12 |
MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF
WAARDENBURG SYNDROME, TYPE II; WS2
|
| MLH1 |
GDB:249617 | 3p23-3p22 3p21.3-3p21.3 |
COLON CANCER, FAMILIAL, NONPOLYPOSIS TYPE 2; FCC2
|
| MYL3 |
GDB:120218 | 3p21.3-3p21.2 |
MYOSIN, LIGHT CHAIN, ALKALI, VENTRICULAR AND SKELETAL SLOW; MYL3
|
| OPA1 |
GDB:118848 | 3q28-3q29 |
OPTIC ATROPHY 1; OPA1
|
| PBXP1 |
GDB:125352 | 3q22-3q23 |
PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR-1; PBX1
|
| PCCB |
GDB:119474 | 3q21-3q22 |
GLYCINEMIA, KETOTIC, II
|
| POU1F1 |
GDB:129070 | 3p11-3p11 |
POU DOMAIN, CLASS 1, TRANSCRIPTION FACTOR 1; POU1F1
|
| PROS1 |
GDB:120721 | 3p11-3q11 3p11.1-3q11.2 |
PROTEIN S, ALPHA; PROS1
|
| PTHR1 |
GDB:138128 | 3p22-3p21.1 |
PARATHYROID HORMONE RECEPTOR 1; PTHR1
|
| RCA1 |
GDB:230233 | 3p14.2-3p14.2 |
RENAL CARCINOMA, FAMILIAL, ASSOCIATED 1; RCA1
|
| RHO |
GDB:120347 | 3q21.3-3q24 |
RHODOPSIN; RHO
|
| SCA7 |
GDB:454471 | 3p21.1-3p12 |
SPINOCEREBELLAR ATAXIA 7; SCA7
|
| SCLC1 |
GDB:9955750 | 3p23-3p21 |
SMALL-CELL CANCER OF THE LUNG; SCCL
|
| SCN5A |
GDB:132152 | 3p21-3p21 |
SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA POLYPEPTIDE; SCN5A
|
| SI |
GDB:120377 | 3q25.2-3q26.2 |
DISACCHARIDE INTOLERANCE I
|
| SLC2A2 |
GDB:119995 | 3q26.2-3q27 3q26.1-3q26.3 |
SOLUTE CARRIER FAMILY 2, MEMBER 2; SLC2A2
FANCONI-BICKEL SYNDROME; FBS
|
| TF |
GDB:120432 | 3q21-3q21 |
TRANSFERRIN; TF
|
| TGFBR2 |
GDB:224909 | 3p22-3p22 3pter-3p24.2 |
TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II; TGFBR2
|
| THPO |
GDB:374007 | 3q26.3-3q27 |
THROMBOPOIETIN; THPO
|
| THRB |
GDB:120731 | 3p24.1-3p22 3p24.3-3p24.3 |
THYROID HORMONE RECEPTOR, BETA; THRB
|
| TKT |
GDB:132402 | 3p14.3-3p14.3 |
WERNICKE-KORSAKOFF SYNDROME
|
| TM4SF1 |
GDB:250815 | 3q21-3q25 |
TUMOR-ASSOCIATED ANTIGEN L6; TAAL6
|
| TRH |
GDB:128072 | 3pter-3qter |
THYROTROPIN-RELEASING HORMONE DEFICIENCY
|
| UMPS |
GDB:120482 | 3q13-3q13 |
OROTICACIDURIA I
|
| UQCRC1 |
GDB:141850 | 3p21.3-3p21.2 3p21.3-3p21.3 |
UBIQUINOL-CYTOCHROME c REDUCTASE CORE PROTEIN I; UQCRC1
|
| USH3A |
GDB:392645 | 3q21-3q25 |
USHER SYNDROME, TYPE III; USH3
|
| VHL |
GDB:120488 | 3p26-3p25 |
VON HIPPEL-LINDAU SYNDROME; VHL
|
| WS2A |
GDB:128053 | 3p14.2-3p13 |
MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MITF
WAARDENBURG SYNDROME, TYPE II; WS2
|
| XPC |
GDB:134769 | 3p25.1-3p25.1 |
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC
|
| ZNF35 |
GDB:120507 | 3p21-3p21 |
ZINC FINGER PROTEIN-35; ZNF35
|